Concepedia

Albertas Ulys

AU

25

Publications

2K

Citations

19

H-Index

2008

Active since

Affiliations

National Cancer Institute(Current)

Vilnius University

Lithuanian University of Health Sciences

Institut Gustave Roussy

Carolina Urologic Research Center

Albertas Ulys is an author at National Cancer Institute specializing in medicine, urology, and oncology.

ORCID

Top concepts

Publications per year

2008–2024

25

Publications

25

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

Karim Fizazi, Neal D. Shore, Teuvo L.J. Tammela et al. · New England Journal of Medicine · 2019 · 890 citations · Full text

Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide

Karim Fizazi, Neal D. Shore, Teuvo L.J. Tammela et al. · New England Journal of Medicine · 2020 · 341 citations · Full text

Phase III, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK-700) Plus Prednisone With Placebo Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer That Has Progressed During or After Docetaxel-Based Therapy: ELM-PC 5

Karim Fizazi, Robert J. Jones, Stéphane Oudard et al. · Journal of Clinical Oncology · 2015 · 151 citations · Full text

Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial

Fred Saad, Egils Vjaters, Neal D. Shore et al. · Journal of Clinical Oncology · 2024 · 102 citations · Full text

Clinical significance of miRNA host gene promoter methylation in prostate cancer

Kristina Daniūnaitė, Monika Dubikaityte, Povilas Gibas et al. · Human Molecular Genetics · 2017 · 55 citations · Full text

, , +19

Rows per page

1–5 of 25